PT G20210A, factors V G1691A and 1299 His–Arg mutations and tamoxifen-associated thromboembolism in patients with breast cancer

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.